Citation Impact
Citing Papers
Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group
2008
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients
2008
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
2007
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization
2009
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity
2010
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
2000
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML
2010
Structure and function of the spleen
2005 Standout
Successful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated Donors
1990
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes
2006
Cancer to bone: a fatal attraction
2011 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.
1997
Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients
2007
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen.
1990
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
2000
New agents in myelodysplastic syndromes
2006
Acute Myeloid Leukemia in the Elderly
2008
Immunorestitution Disease Involving the Innate and Adaptive Response
2000
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study
2005
Successful intensive chemotherapy followed by autologous hematopoietic cell transplantation in a patient with acute myeloid leukemia and hepatosplenic candidiasis: case report and review of literature
2009
Diagnosis and management of refractoriness to platelet transfusion
2001
Tuberculosis in stem cell transplant patients
2006
Risk assessment in haemotopoietic stem cell transplantation: Disease and disease stage
2007
Risk assessment in haematopoietic stem cell transplantation: Histocompatibility
2007
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial
2006
Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study.
1990
Transfusion Medicine — Blood Transfusion
1999 Standout
Prospective observational study of low thresholds for platelet transfusion in adult dengue patients
2009
Collection and transfusion of blood and blood components in the United States, 1992
1995
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Acute myeloid leukaemia
2006
Delivery technologies for cancer immunotherapy
2019 Standout
Anesthesiology
1997 Standout
Acute Myeloid Leukemia and the Position of Autologous Stem Cell Transplantation
2007
A Controlled Trial of Tranexamic Acid Therapy for the Reduction of Bleeding During Treatment of Acute Myeloid Leukemia
1995
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Streptococcus pneumoniae Bacteremia in Patients With Cancer
2005
Immune Thrombocytopenic Purpura
2002 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
The myelodysplastic syndrome.
1989
Graft-versus-host disease
2009 Standout
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients
2001
The Threshold for Prophylactic Platelet Transfusions in Adults with Acute Myeloid Leukemia
1997
Reliability of automated platelet counts: Comparison with manual method and utility for prediction of clinical bleeding
1995
Tuberculosis in allogeneic stem cell transplant recipients: still a problem in the 21st century
2004
Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment
2004
The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine
2013 Standout
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
1993
Dengue
2012 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Growth factors in acute myeloid leukaemia
2001
The cancer stem cell: premises, promises and challenges
2011 Standout
Neutrophils, from Marrow to Microbes
2010 Standout
A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger
2002
Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene
2000
The hematopoietic stem cell niche
2011
An update on the management of severe idiopathic aplastic anaemia in children
2007
Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
2004
New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis
2012
Disseminated Intravascular Coagulation
1999 Standout
Acute Myeloid Leukemia
1999
Immunity to fungal infections
2011 Standout
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia
2011
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
HEPATOSPLENIC CANDIDIASIS
2000
The Human Spleen During Physiological Stress
2002
The bleeding newborn.
1975
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Development of the human coagulation system in the full-term infant
1987 Standout
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
1998 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Meta-analysis: Effect of Prophylactic Hematopoietic Colony-Stimulating Factors on Mortality and Outcomes of Infection
2007
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
2008
Deficiency of protein C in congenital thrombotic disease.
1981 Standout
Myelodysplastic Syndromes Clinical Practice Guidelines in Oncology
2006
Maturation of the hemostatic system during childhood
1992 Standout
Acute Myeloid Leukemia
2015 Standout
G-CSF and GM-CSF in Neutropenia
2015
Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype
2008
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Leukocyte Reduction and Ultraviolet B Irradiation of Platelets to Prevent Alloimmunization and Refractoriness to Platelet Transfusions
1997
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.
1996
Acute Myeloid Leukemia and Acute Promyelocytic Leukemia
2003
Prognostic value of cytogenetic findings in adults with acute myeloid leukemia.
2000
Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants
2000
Platelet Transfusion for Patients With Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance
2005
Assessment of Differences in Patient Populations Selected for or Excluded From Participation in Clinical Phase III Acute Myelogenous Leukemia Trials
2003
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993
1999 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Acute Profound Thrombocytopenia After c7E3 Fab (Abciximab) Therapy
1997
Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
1994
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
2001 Standout
Double Induction Containing Either Two Courses or One Course of High-Dose Cytarabine Plus Mitoxantrone and Postremission Therapy by Either Autologous Stem-Cell Transplantation or by Prolonged Maintenance for Acute Myeloid Leukemia
2006
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm
2002
Risk Assessment in Patients with Acute Myeloid Leukemia and a Normal Karyotype
2005
Age-Specific Differences in Oncogenic Pathway Dysregulation in Patients With Acute Myeloid Leukemia
2009
COAGULATION DISORDERS IN CANCER
1996
High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated
2008
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells
2010 StandoutNobel
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Fibrinogen ""New York"--an abnormal fibrinogen associated with thromboembolism: functional evaluation
1975
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group
2007
The Role of B7 Costimulation in CD4/CD8 T Cell Homeostasis
2000 StandoutNobel
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
Risks, Costs, and Alternatives to Platelet Transfusions
1999
Improved Liver Function in Patients with Liver Cirrhosis After Autologous Bone Marrow Cell Infusion Therapy
2006
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Stem Cell Transplantation for Secondary Acute Myeloid Leukemia: Evaluation of Transplantation as Initial Therapy or Following Induction Chemotherapy
1997
Treatment of Therapy-Related Leukemia and Myelodysplastic Syndrome
1993
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse
2005
Works of J Gmür being referenced
Rapid and automated processing of bone marrow grafts without Ficoll density gradient for transplantation of cryopreserved autologous or ABO-incompatible allogeneic bone marrow.
1992
Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia
1991
Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid Leukemia
2003
Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2[ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors
1989
Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
1999
Mycobacterial Infection: A Difficult and Late Diagnosis in Stem Cell Transplant Recipients
2004
Detection of 16 p deletions by FISH in patients with inv(16) or t(16;16) and acute myeloid leukemia (AML)
1997
Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG)
1990
Bone marrow transplantation with unrelated donors: what is the probability of identifying an HLA-A/B/Cw/DRB1/B3/B5/DQB1-matched donor?
2000
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.
1997
Reptilase®‐R—A New Reagent in Blood Coagulation
1971
Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes. Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG).
1989
A Restrictive Platelet Transfusion Policy Allowing Long-Term Support of Outpatients With Severe Aplastic Anemia
1999
Functional hyposplenia after allogeneic bone marrow transplantation is detected by epinephrine stimulation test and splenic ultrasonography
1988
[Blood coagulation studies in cord blood: fetal fibrinogen?].
1970
Hepatic Lesions of Chronic Disseminated Candidiasis May Become Invisible During Neutropenia
1997
Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party.
1988
Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT)
1998
Delayed alloimmunization using random single donor platelet transfusions: a prospective study in thrombocytopenic patients with acute leukemia
1983